← FDA DRUG APPROVALS

FDA ANDA · ANDA213409

NIMODIPINE

Sponsor: ALKEM LABS LTD

APPLICATION
ANDA213409
TYPE
ANDA
ORIGINAL APPROVAL
2025-01-22
LATEST ACTION
2025-01-22
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
None (Tentative Approval), Prescription

Products

NIMODIPINENone (Tentative Approval)
NIMODIPINE 60MG/10ML · SOLUTION · ORAL
NIMODIPINEPrescription
NIMODIPINE 6MG/ML · SOLUTION · ORAL

Approval history

2025-01-22UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →